StonvexLoading…
StonvexStonvexStonvexCore line items from SMSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.22M | $17.36M | $13.39M | $9.04M |
Operating Income | $-3.37M | $-29.01M | $-24.65M | $-20.16M |
Net Income | $-3.90M | $-29.33M | $-24.77M | $-20.24M |
EPS (Diluted) | $-0.15 | $-1.46 | $-1.30 | $-1.08 |
Total Assets | $25.79M | $24.97M | $27.13M | $29.58M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.74M | $1.49M | $1.39M | $1.40M |
Free Cash Flow OCF − CapEx | $-3.76M | $-7.28M | $-5.06M | $-2.90M |
Shares Outstanding | 25.61M | 25.80M | 21.48M | 19.38M |